US$ 22.76
dallas semaglutide gastric intestinal obstruction law firm louisiana semaglutide digestive blockage attorney in louisiana semaglutide gi obstruction lawyer in louisiana Louisiana Diabetes Drugs & Gastrointestinal Injuries semaglutide gastric intestinal obstruction law
Description
Coverage varies across the entire class of GLP-1 receptor agonists, with diabetes indications typically covered but obesity indications excluded in most states

Many insurers may impose step therapy requirements, favoring other GLP-1 RAs before approving tirzepatide

Accessed January 2026

Undereating despite appetite suppression poses real risks: fatigue, dizziness, hair loss, and hormonal disruption can occur at extreme deficits below 1,200 calories daily
The agency said patients also should avoid buying the drugs from unfamiliar sources

Hepatitis B infection as a possible cause of focal segmental glomerulosclerosis (FSGS)